Overdetection, Overtreatment and Costs in Prostate-Specific Antigen Screening for Prostate Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6605422
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Role of Prostate-Specific Antigen in Prostate Cancer Screening

Romanian Review of Laboratory Medicine
2014English

Recommendations on Screening for Prostate Cancer With the Prostate-Specific Antigen Test

CMAJ
Medicine
2014English

Prostate Cancer Screening With Prostate-Specific Antigen: Where Are We Going?

Cancer
Cancer ResearchOncology
2017English

Managing Localized Prostate Cancer in the Era of Prostate-Specific Antigen Screening

Cancer
Cancer ResearchOncology
2013English

SIGNIFICANCE AND FUTURE OF PROSTATE-SPECIFIC ANTIGEN (PSA, Tandem) IN THE MASS SCREENING FOR PROSTATE CANCER

The KITAKANTO Medical Journal
1994English

Mp40-03 Changes in Prostate Specific Antigen Screening and Prostate Cancer Diagnosis After Guideline Changes

Journal of Urology
Urology
2018English

Discoveries and Application of Prostate-Specific Antigen, and Some Proposals to Optimize Prostate Cancer Screening

Cancer Management and Research
Oncology
2016English

Tackling Overtreatment of Prostate Cancer

Cancer
Cancer ResearchOncology
2011English

Overdiagnosis and Overtreatment of Prostate Cancer

European Urology
Urology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy